Skip to main content


488 result(s) for 'author#Mark Levine' within BMC

Page 25 of 25

Sort by: Relevance | Date

  1. The hallmark of heart failure is increased blood volume. Quantitative blood volume measures are not conveniently available and are not tested in heart failure management. We assess ferumoxytol, a marketed pare...

    Authors: Rajiv Ramasawmy, Toby Rogers, Miguel A. Alcantar, Delaney R. McGuirt, Jaffar M. Khan, Peter Kellman, Hui Xue, Anthony Z. Faranesh, Adrienne E. Campbell-Washburn, Robert J. Lederman and Daniel A. Herzka
    Citation: Journal of Cardiovascular Magnetic Resonance 2018 20:62
  2. The development and demonstration of incremental trainee autonomy is required by the ACGME. However, there is scant published research concerning autonomy of ophthalmology residents in the outpatient clinic se...

    Authors: Eric L. Singman, Divya Srikumaran, Laura Green, Jing Tian and Peter McDonnell
    Citation: BMC Medical Education 2017 17:105
  3. We present a model for tagging gene and protein mentions from text using the probabilistic sequence tagging framework of conditional random fields (CRFs). Conditional random fields model the probability P(t|o) of...

    Authors: Ryan McDonald and Fernando Pereira
    Citation: BMC Bioinformatics 2005 6(Suppl 1):S6

    This article is part of a Supplement: Volume 6 Supplement 1

  4. Pathogenic germline mutations in BRCA1 and BRCA2 (BRCA1/2) account for the majority of hereditary breast and/or ovarian cancers worldwide. To refine the spectrum of BRCA1/2 mutations and to accurately estimate th...

    Authors: Muhammad Usman Rashid, Noor Muhammad, Humaira Naeemi, Faiz Ali Khan, Mariam Hassan, Saima Faisal, Sidra Gull, Asim Amin, Asif Loya and Ute Hamann
    Citation: Hereditary Cancer in Clinical Practice 2019 17:27
  5. Recurrent respiratory papillomatosis (RRP), characterized by the recurrent growth of benign tumors of the respiratory tract, is caused by infection with human papillomavirus (HPV), predominantly types 6 and 11...

    Authors: David W. Rosenthal, James A. DeVoti, Bettie M. Steinberg, Allan L. Abramson and Vincent R. Bonagura
    Citation: Molecular Medicine 2012 18:18091338
  6. Ipilimumab (IPI), an anti-CTLA-4 antibody, and vemurafenib (VEM), a BRAF inhibitor, have distinct mechanisms of action and shared toxicities (e.g., skin, gastrointestinal [GI] and hepatobiliary disorders) that...

    Authors: Asim Amin, David H. Lawson, April K.S. Salama, Henry B. Koon, Troy Guthrie Jr, Sajeve S. Thomas, Steven J. O’Day, Montaser F. Shaheen, Bin Zhang, Stephen Francis and F. Stephen Hodi
    Citation: Journal for ImmunoTherapy of Cancer 2016 4:44
  7. AGS-003 is an autologous immunotherapy prepared from fully matured and optimized monocyte-derived dendritic cells, which are co-electroporated with amplified tumor RNA plus synthetic CD40L RNA. AGS-003 was eva...

    Authors: Asim Amin, Arkadiusz Z Dudek, Theodore F Logan, Raymond S Lance, Jeffrey M Holzbeierlein, Jennifer J Knox, Viraj A Master, Sumanta K Pal, Wilson H Miller Jr, Lawrence I Karsh, Irina Y Tcherepanova, Mark A DeBenedette, W Lee Williams, Douglas C Plessinger, Charles A Nicolette and Robert A Figlin
    Citation: Journal for ImmunoTherapy of Cancer 2015 3:14
  8. Empirical antibiotic coverage for atypical pathogens in community-acquired pneumonia (CAP) has long been debated, mainly because of a lack of epidemiological data. We aimed to assess both testing for atypical ...

    Authors: Andrea Gramegna, Giovanni Sotgiu, Marta Di Pasquale, Dejan Radovanovic, Silvia Terraneo, Luis F. Reyes, Ester Vendrell, Joao Neves, Francesco Menzella, Francesco Blasi, Stefano Aliberti and Marcos I. Restrepo
    Citation: BMC Infectious Diseases 2018 18:677

    The Correction to this article has been published in BMC Infectious Diseases 2020 20:748